PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs The global market for Blue Eye Disease Vaccines was estimated to be worth…
Author: QYResearch
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 6 countries (include United States, Germany, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Cholera Vaccines Oral Live Market Opportunity Analysis Report 2024: Regional Markets and Segments
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global market for Cholera Vaccines Oral Live was estimated to be worth US$ 85 million in 2023 and is forecast to a…
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Global Market in 2024: A Comprehensive Analysis of Opportunities and Threats
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed…
Measles, Mumps, and Rubella Virus Vaccine Market Competitive Analysis Report 2024-2030: Competitors and Strategies Examined
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The global market for Measles, Mumps, and Rubella Virus Vaccine was estimated to be worth US$ 388 million in 2023 and is forecast to a readjusted…
Meningococcal Group B Vaccine Market Report 2024: Data-Driven Insights on Trends and Opportunities
Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. The global market for Meningococcal Group B Vaccine was estimated to be worth US$ 1107 million in 2023 and is forecast to a…
Duck Virus Enteritis Vaccine Market Strategies for Expansion Analysis Report: Opportunities and Challenges Ahead
Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. The global market for Duck Virus Enteritis Vaccine was estimated to be…
Menomune-A & C & Y & W-135 Market Development Strategy Report 2024: Expanding Reach and Impact
Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. The global market for Menomune-A…
Lyophilized IVIG Market Competitive Analysis Report 2024-2030: Competitors and Strategies Examined
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors. The global market for Lyophilized IVIG was estimated to be worth US$…
10-Valent Pneumococcal Polysaccharide Vaccine Market Expansion Report 2024: Effective Strategies and Market Expansion
Pneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F. The global…
Akabane Vaccines Market Report 2024: Trend Analysis and Future Prospects
Vaccine for Akabane disease The global market for Akabane Vaccines was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 91 million by 2030 with a…